HomeSONN • NASDAQ
add
Sonnet BioTherapeutics Holdings, Inc.
Previous close
$1.55
Day range
$1.50 - $1.55
Year range
$1.38 - $18.72
Market cap
4.54M USD
Avg Volume
143.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.00M | 5,268.84% |
Operating expense | 1.96M | 200.46% |
Net income | -3.16M | -170.49% |
Net profit margin | -316.07 | 94.96% |
Earnings per share | -1.56 | 37.10% |
EBITDA | -2.85M | -123.12% |
Effective tax rate | -5.28% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.86M | 60.90% |
Total assets | 7.18M | 34.55% |
Total liabilities | 3.15M | 13.75% |
Total equity | 4.04M | — |
Shares outstanding | 3.07M | — |
Price to book | 1.16 | — |
Return on assets | -143.14% | — |
Return on capital | -375.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.16M | -170.49% |
Cash from operations | -2.91M | 5.87% |
Cash from investing | — | — |
Cash from financing | 7.62M | 98.56% |
Net change in cash | 4.71M | 530.68% |
Free cash flow | -1.68M | 38.52% |
About
Founded
1999
Headquarters
Website
Employees
13
